Mingjun Bai

机构：Sun Yat-sen University, Third Affiliated Hospital of Sun Yat-sen University

发表论文 17 篇 · 总被引 210 次 · h-index 8

代表论文

• Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort study (2016 · European Radiology · 被引 55)
• Albumin-to-Alkaline Phosphatase Ratio as an Independent Prognostic Factor for Overall Survival of Advanced Hepatocellular Carcinoma Patients without Receiving Standard Anti-Cancer Therapies (2017 · Journal of Cancer · 被引 54)
• Neutrophil-to-Apolipoprotein A1 Ratio Predicted Overall Survival in Hepatocellular Carcinoma Receiving Transarterial Chemoembolization (2021 · The Oncologist · 被引 19)
• Reduced Glutathione Protects Human Hepatocytes from Palmitate-Mediated Injury by Suppressing Endoplasmic Reticulum Stress Response (2011 · Hepatogastroenterology · 被引 19)
• Transarterial Chemoembolization (TACE) Combined with Lenvatinib versus TACE Alone in Intermediate-Stage Hepatocellular Carcinoma Patients Beyond Up-To-Seven Criteria: A Retrospective, Propensity Score-Matched Analysis (2024 · Academic Radiology · 被引 17)
• Safety and efficacy of 125I brachytherapy for bilateral lung recurrences from hepatocellular carcinoma after resection or ablation (2019 · Journal of Cancer Research and Clinical Oncology · 被引 15)